Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Koenig

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Science (New York, N.Y.)|December 2, 2017
The target landscape of clinical kinase drugsSusan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm, et al.
Immunity|September 30, 2021
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Science (New York, N.Y.)|December 2, 2017
The target landscape of clinical kinase drugsSusan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm, et al.
Immunity|September 30, 2021
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, et al.
Pageof 3